In 2017, an estimated 1,680,000 new cases of cancer will be diagnosed in the United States and 600,000 people will die from the disease.
In 2017, The National Cancer Institute estimated that 15.5 million people were living with cancer of any site in the United States. "Living with" being defined as in treatment, remission or cured and equates to approximately 4.6% of the population.
The most common cancers listed in descending order according to estimated new cases in 2018 are detailed in the table below.
Smaller studies excepted, few studies have been conducted to understand LDN’s effectiveness against cancer. In 2016, researchers at St. George’s University in London found that LDN reduced tumor growth by interfering with cancer cell signaling. Published in the International Journal of Oncology, the Abstract summarized: "Our data support further the idea that LDN possesses anticancer activity, which can be improved by modifying the treatment schedule."
Digital Compounder specializes in social advertising for compounding pharmacies.
Interested in learning more about how social advertising can help your compounding pharmacy to target patients that can benefit from LDN? Please sign up for our mailing list.